Literature DB >> 35283512

Sorafenib-Induced Eruptive Melanocytic Lesions.

Hui-Chun Chen1, Sheau-Chiou Chao2.   

Abstract

Entities:  

Year:  2021        PMID： 35283512      PMCID： PMC8906327          DOI： 10.4103/ijd.ijd_87_21

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN： 0019-5154            Impact factor:   1.494


× No keyword cloud information.
  4 in total

1.  Sorafenib-induced eruptive melanocytic lesions.

Authors:  Heidi H Kong; Vincent Sibaud; Maria L Chanco Turner; Tito Fojo; Thomas J Hornyak; Christine Chevreau
Journal:  Arch Dermatol       Date:  2008-06

Review 2.  Eruptive nevi associated with medications (ENAMs).

Authors:  Benjamin M Perry; Anne Nguyen; Bryce L Desmond; Collin M Blattner; R Scott Thomas; R John Young
Journal:  J Am Acad Dermatol       Date:  2016-05-27       Impact factor: 11.527

3.  Number of melanocytic nevi as a major risk factor for malignant melanoma.

Authors:  E A Holly; J W Kelly; S N Shpall; S H Chiu
Journal:  J Am Acad Dermatol       Date:  1987-09       Impact factor: 11.527

4.  Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings.

Authors:  Mauro Alaibac; Stefano Piaserico; Carlo Riccardo Rossi; Mirto Foletto; Gabriella Zacchello; Paolo Carli; Anna Belloni-Fortina
Journal:  J Am Acad Dermatol       Date:  2003-12       Impact factor: 11.527
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.